Caplight Directory>Companies>ABclonal-preview>Abclonal-china


ABclonal

ABclonal

Private
Wuhan, HubeiHealthcare & Life Scienceswww.abclonal.com.cn

Last Round

Series D

Dec 8, 2021

Total Funding Raised

$284.02M

Company Overview

ABclonal China is a biotechnology and contract research organization (CRO) company that manufactures laboratory supplies and offers professional services to global scientific research institutions, drug development organizations, and the diagnostic industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts, Subscription SaaS

AI Layer

Non-AI

Keywords

antibodiesresearch reagentscontract research organizationCROmonoclonal antibodiesrecombinant proteinsELISA kitsNGS library preparation kitscustom antibody productionantibody supplierpolyclonal antibodiesin vitro diagnosticIVDlife science toolspeptide synthesisprotein expressionmolecular biology reagentssingle B-cell antibody discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ABclonal Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ABclonal Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DDec 8, 2021
Series CFeb 22, 2021
Series BAug 1, 2016
Series AMar 1, 2016
View all Funding Rounds

ABclonal Investors

Notable investors and investment history

InvestorRounds
Loyal Valley CapitalSeries D
Oriza FOFsSeries C
LYFE CapitalSeries C
C&D Emerging Industry Equity InvestmentSeries C
Sigma Square CapitalSeries C
HongShanSeries D, Series C
View all Investors

ABclonal Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ABclonal Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ABclonal's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuhan, Hubei
Year Founded2011
Last FundingDec 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.